doi: 10.1016/s1470-2045(05)70273-4.
Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment
- PMID: 16094770
- DOI: 10.1016/s1470-2045(05)70273-4
Item in Clipboard
Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment
Lancet Oncol.
2005 Aug.
No abstract available
Comment in
-
Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer.Lancet Oncol. 2005 Oct;6(10):736; author reply 737. doi: 10.1016/S1470-2045(05)70365-X. Lancet Oncol. 2005. PMID: 16198976 No abstract available.
-
Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer.Lancet Oncol. 2005 Oct;6(10):736-7; author reply 737. doi: 10.1016/S1470-2045(05)70366-1. Lancet Oncol. 2005. PMID: 16198977 No abstract available.
-
Oral contraceptives, menopausal treatment, and cancer.Lancet Oncol. 2007 Oct;8(10):867; author reply 867-8. doi: 10.1016/S1470-2045(07)70297-8. Lancet Oncol. 2007. PMID: 17913660 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Medical